Therapy of Angina Pectoris

  • Peter F. Cohn


Chapter 2 has described the pathoanatomy of coronary artery disease in humans and has discussed the pathophysiologic mechanisms that form the basis for many of the clinical manifestations of this disease. In the present chapter, the therapy of angina pectoris will be reviewed, including the chronic (stable), unstable, and variant types. Among the points of controversy that will be commented on in this chapter are the modification of risk factors and the role of exercise, clinical value of the calcium-antagonists compared to ß-adrenergic blocking agents, role of coronary angioplasty, prognosis of medically treated patients in the present era, selection of less disabled patients for coronary artery bypass surgery, reappearance of symptoms after surgical therapy, management of coronary artery disease associated with other disease states (both cardiac and noncardiac), and the role of medical and “prophylactic” coronary artery bypass surgery in patients with coronary artery disease who need to undergo noncardiac surgery.


Coronary Artery Disease Angina Pectoris Unstable Angina Myocardial Blood Flow Coronary Artery Bypass Surgery 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Rosenman, R.H., Brand, R J., Scholtz, R.I., and Friedman, M. Multivariate prediction of coronary heart disease during 8.5 year follow-up in the Western Collaborative Group Study. Am. J. Cardiol. 37: 903, 1976.PubMedCrossRefGoogle Scholar
  2. 2.
    Friedman, M., Thoresen, C.E., Gill, J J., Ulmer, D., Thompson, L., Powell, L., Price, V., Elek, S.R., Rabind, D.D., Breall, W.S., Piaget, G., Dixon, T., Bourg, E., Levy, R.A., and Tasto, D.L. Feasibility of altering type A behavior pattern after myocardial infarction. Recurrent coronary prevention project study: Methods, baseline results and preliminary findings. Circulation 66: 83, 1982.PubMedCrossRefGoogle Scholar
  3. 3.
    Joy, M., Pollard, C.M., and Numan, T.O. Diurnal variation in exercise responses in angina pectoris. Br. Heart J. 48: 156, 1982.PubMedCrossRefGoogle Scholar
  4. 4.
    Heaton, W.H., Marr, K.C., Capurro, N.L., Goldstein, R.E., and Epstein, S.E. Beneficial effect of physical training on blood flow to myocardium perfused by chronic collaterals in the exercising dog. Circulation 57: 575, 1978.PubMedGoogle Scholar
  5. 5.
    Schaper, W. Influence of physical exercise on coronary collateral blood flow in chronic experimental two-vessel occlusion. Circulation 65: 905, 1982.PubMedCrossRefGoogle Scholar
  6. 6.
    Clausen, J.P. Circulatory adjustments to dynamic exercise and effect of physical training in normal subjects and in patients with coronary artery disease. Prog. Cardiovasc. Dis. 18: 459, 1976.PubMedCrossRefGoogle Scholar
  7. 7.
    Hagberg, J.M., Ehsani, A.A., and Holloszy, J.O. Effect of 12 months of intense exercise training on stroke volume in patients with coronary artery disease. Circulation 67: 1194, 1983.PubMedCrossRefGoogle Scholar
  8. 8.
    Redwood, D.R., Rosing, D.R., and Epstein, S.E. Circulatory and symptomatic effects of physical training in patients with coronary artery disease and angina pectoris. N. Engl. J. Med. 286: 959, 1972.PubMedCrossRefGoogle Scholar
  9. 9.
    Clausen, J.P. and Trap Jensen, J. Heart rate and arterial blood pressure during exercise in patients with angina pectoris: Effect of training and of nitroglycerin. Circulation 53: 436, 1976.PubMedGoogle Scholar
  10. 10.
    Fox, S.M., Naughton, J.P., and Gorman, P.A. Physical activity and cardiovascular health: The exercise prescription. Mod. Concepts Cardiovasc. Dis. 41: 21, 1972.PubMedGoogle Scholar
  11. 11.
    Amsterdam, E.A., Wilmore, J.H., and De-Maria, A.N. Exercise in Cardiovascular Health and Disease. New York: Yorke Medical Books, 1977, p. 313.Google Scholar
  12. 12.
    Kannel, W.B. Update on the role of cigarette smoking in coronary artery disease. Am. Heart J. 101: 319, 1981.PubMedCrossRefGoogle Scholar
  13. 13.
    Folts, J.D. and Bonebrake, F.C. The effects of cigarette smoke and nicotine on platelet thrombus formation in stenosed dog coronary arteries: Inhibition with phentolamine. Circulation 65: 465, 1982.PubMedCrossRefGoogle Scholar
  14. 14.
    Klein, L.W., Pichard A.D., Holt, J., Smith, H., Gorlin, R., and Teichholz, L.E. Effects of chronic tobacco smoking on the coronary circulation. J. Am, Coll. Cardiol. 1: 421, 1983.CrossRefGoogle Scholar
  15. 15.
    Aronow, W.S. Smoking, carbon monoxide, and coronary heart disease. Circulation 48: 1169, 1973.PubMedGoogle Scholar
  16. 16.
    Aronow, W.S., Stemmer, E.A., Wood, B., Zweig, S., Tsao, K., and Raggio, L. Carbon monoxide and ventricular fibrillation threshold in dogs with acute myocardial injury. Am. Heart J. 95: 754, 1978.PubMedCrossRefGoogle Scholar
  17. 17.
    Foster, J.R. Arrhythmogenic effects of carbon monoxide in experimental acute myocardial ischemia: Lack of slowed conduction and ventricular tachycardia. Am. Heart J. 102: 876, 1981.PubMedCrossRefGoogle Scholar
  18. 18.
    Kaufman, D.W., Helmrich, S.P., Rosenberg, L., Miettinen, O.S., and Shapiro, S. Nicotine and carbon monoxide content of cigarette smoke and the risk of myocardial infarction in young men. N. Engl. J. Med. 308: 409, 1983.PubMedCrossRefGoogle Scholar
  19. 19.
    Aronow, W.S. Effect of passive smoking on angina pectoris. N. Engl. J. Med. 299: 21, 1978.PubMedCrossRefGoogle Scholar
  20. 20.
    Frolich, E.D. Newer concepts in antihypertensive drugs. Prog. Cardiovasc. Dis. 20: 385, 1978.CrossRefGoogle Scholar
  21. 21.
    Stokes, G.S., Oates, H.F., and MacCarthy, E.P. Antihypertensive therapy: New pharmacological approaches. Am. Heart J. 100: 741, 1980.PubMedCrossRefGoogle Scholar
  22. 22.
    Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure: A cooperative study. JAMA 237: 255, 1977.CrossRefGoogle Scholar
  23. 23.
    Kaplan, N.M. New choices for the initial drug therapy of hypertension. Am. J. Cardiol. 51: 1786, 1983.PubMedCrossRefGoogle Scholar
  24. 24.
    Case, D.B., Atlas, S.A., Sullivan, and Laragh, J.H. Acute and chronic treatment of severe and malignant hypertension with the oral angiotensin-converting enzyme inhibitor captopril. Circulation 64: 765, 1981.PubMedCrossRefGoogle Scholar
  25. 25.
    Kaplan, S.A., Lippe, B.M., Brinkman, C.R. III, Davidson, M.B., and Geffner, M.E. Diabetes mellitus. Am. Intern. Med. 96: 635, 1982.Google Scholar
  26. 26.
    Havel, RJ. Treatment of hyperlipidemias: Where do we start? Am. J Med. 73: 301, 1982.PubMedCrossRefGoogle Scholar
  27. 27.
    St. Clair, R.W. Atherosclerosis regression in animal models: Current concepts of cellular and biochemical mechanisms. Prog. Cardiovasc. Dis. 26: 109, 1983.CrossRefGoogle Scholar
  28. 28.
    Blankenhorn, D.H., Brooks, S.H., Selzer, R.H., and Barndt, T., Jr. The rate of atherosclerotic change during treatment of hyperlipoproteinemia. Circulation 57: 355, 1978.PubMedGoogle Scholar
  29. 29.
    Grundy, S.M., Bilheimer, D., Blackburn, H., Brown, W.V., Kwiterovich, P.O., Jr., Mattson, F., Schoenfeld, G., and Weidman, W.H. Rationale of the diet-heart statement of the American Heart Association: Report of Nutrition Committee. Circulation 65: 839A, 1982.Google Scholar
  30. 30.
    Brown, W.V., Goldberg, I.J. and Ginsberg H.N. Treatment of common lipoprotein disorders Prog. Cardiovasc. Dis. 27: 1, 1984.PubMedCrossRefGoogle Scholar
  31. 31.
    Jones, P. and Gotto, A.M. Jr. Drug treatment of hyperlipidemia. Mod. Concepts Cardiovasc. Dis. 53: 53, 1984.Google Scholar
  32. 32.
    Brensike, J.F., Levy, R.I., Kelsey, S.F., Pass-amani, E.R., Richardson, J.M., Loh, I.K., Stone, NJ., Aldrich, R.F., Battaglini, J.W., Moriarty, DJ., Fisher, M.R., Friedman, L., Friedewald, W., Detre, K.M., and Epstein, S.E. Effects of therapy with cholestyramine on progression of coronary atherosclerosis: Results of NHLBI Type II Coronary Intervention Study. Circulation 69: 313, 1984.PubMedCrossRefGoogle Scholar
  33. 33.
    Hartung, G.H., Squires, W.G., and Gotto, A.M., Jr. Effect of exercise training on plasma high-density lipoprotein cholesterol in coronary disease patients. Am. Heart J. 101: 181, 1981.PubMedCrossRefGoogle Scholar
  34. 34.
    Gordon, T., Castelli, W.P., Hjortland, M.C., Kannel, W.B., and Dawber, T.R. Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women. Ann. Intern. Med. 87: 393, 1977.PubMedGoogle Scholar
  35. 35.
    Brunton, T.L. On the use of nitrate of amyl in angina pectoris. Lancet 2: 97, 1867.CrossRefGoogle Scholar
  36. 36.
    Cohn, P.F. and Gorlin, R. Physiologic and clinical actions of nitroglycerin. Med. Clin. North Am. 58: 407, 1974.PubMedGoogle Scholar
  37. 37.
    Mason, D.T. and Braunwald, E. The effects of nitroglycerin and amyl nitrate on arteriolar and venous tone in the human forearm. Circulation 32: 755, 1965.PubMedGoogle Scholar
  38. 38.
    Williams, J.F., Jr., Glick, G., and Braunwald, E. Studies on cardiac dimensions in intact unanesthetized man. V. Effects of nitroglycerin. Circulation 49: 146, 1974.Google Scholar
  39. 39.
    Burggraf, G.W. and Parker, J.O. Left ventricular volume changes after amyl nitrite and nitroglycerin in man as measured by ultrasound. Circulation 49: 146, 1974.Google Scholar
  40. 40.
    DeMaria, A.N., Vismara, L.A., Audtiore, K., Amsterdam, E.A., Zelis, R., and Mason, D.T. Effects of nitroglycerin on left ventricular cavity size and cardiac performance determined by ultrasound in man. Am. J. Med. 57: 754, 1974.PubMedCrossRefGoogle Scholar
  41. 41.
    Feldman, R.L., Pepine, C.J., and Conti, C.R. Magnitude of dilatation of large and small coronary arteries by nitroglycerin. Circulation 64: 324, 1981.PubMedCrossRefGoogle Scholar
  42. 42.
    Fuchs, R.M., Brinker, J.A., Guzman, P.A., Kross, D.E., and Yin, F.C.P. Regional coronary blood flow during relief of pacing-induced angina by nitroglycerin: Implications for mechanism of action. Am. J. Cardiol. 50: 19, 1982.Google Scholar
  43. 43.
    Slutsky, R., Battler, A., Gerber, K., Gordon, D., Froelicher, V., Karliner, J., and Ashburn, W. Effect of nitrates on left ventricular size and function during exercise: Comparison of sublingual nitroglycerin and nitroglycerin paste. Am. J. Cardiol. 45: 831, 1980.PubMedCrossRefGoogle Scholar
  44. 44.
    Flessas, A.P. and Ryan, T J. Effects of nitroglycerin on isometric exercise. Am. Heart J. 105: 239, 1983.PubMedCrossRefGoogle Scholar
  45. 45.
    Greenberg, H., Dwyer, E.M., Jr., Jameson, A.G., and Pinkernell, B.H. Effects of nitroglyc-erin on the major determinants of myocardial oxygen consumption. An angiographic and hemodynamic assessment. Am. J. Cardiol. 36: 426, 1975.PubMedCrossRefGoogle Scholar
  46. 46.
    Lecerof, H. Influences of body position on exercise tolerance, heart rate, blood pressure and respiration rate in coronary insufficiency. Br. Heart J. 33: 78, 1971.PubMedCrossRefGoogle Scholar
  47. 47.
    Christensson, B., Karlefors, T., and Westling, H. Hemodynamic effects of nitroglycerin in patients with coronary heart disease. Br. Heart J. 27: 511, 1965.PubMedCrossRefGoogle Scholar
  48. 48.
    Thadani, U., Fung, H.L., Darke, A.C., and Parker, J.O. Oral isosorbide dinitrate in the treatment of angina pectoris: Dose-response relationship and duration of action during acute therapy. Circulation 62: 491, 1980.PubMedGoogle Scholar
  49. 49.
    Degre, S.G., Strappart, G.M., Sobolski, J.C., Berkenboom, G.M., Stoupel, E.E., and Vandermoten, P.P. Effect of oral sustained-released nitroglycerin on exercise capacity in angina pectoris: Dose-response relation and duration of action during double-blind crossover randomized acute therapy. Am. J. Cardiol. 51: 1595, 1983.PubMedCrossRefGoogle Scholar
  50. 50.
    Chiong, M.A., West, R.O., and Parker, J.O. Influence of nitroglycerin on myocardial metabolism and hemodynamics during angina induced by atrial pacing. Circulation 45: 1044, 1972.PubMedGoogle Scholar
  51. 51.
    McAnulty, J.H., Hattenhauer, M.T., Rosch, J., Kloster, F.E., and Rahimtoola, S.H. Improvement in left ventricular wall motion following nitroglycerin. Circulation 51: 140, 1975.PubMedGoogle Scholar
  52. 52.
    McEwan, M.P., Berman, N.D., Morch, J.E., Feiglin, D.H., and McLaughlin, P.R. Effect of intravenous and intracoronary nitroglycerin on left ventricular wall motion and perfusion in patients with coronary artery disease. Am. J. Cardiol. 47: 102, 1981.PubMedCrossRefGoogle Scholar
  53. 53.
    Salel, A.F., Berman, D.S., DeNardo, G.L., and Mason, D.T. Radionuclide assessment of nitroglycerin influence on abnormal left ventricular segmental contraction in patients with coronary artery disease. Circulation 53: 975, 1976.PubMedGoogle Scholar
  54. 54.
    Borer, J.S., Bacharach, S.L., Green, M.B., Kent, K.M., Johnston, G.S., and Epstein, S.E. Effect of nitroglycerin on exercise-induced abnormalities of left ventricular regional function and ejection in coronary artery disease. Assessment of radionuclide cineangiography in symptomatic and asymptomatic patients. Circulation 57: 314, 1978.PubMedGoogle Scholar
  55. 55.
    Bache, RJ., Ball, R.M., Cobb, F.R., Rembert, J.C., and Greenfield, J.C., Jr. Effects of nitroglycerin on transmural myocardial blood flow in the unanesthetized dog. J. Clin. Invest. 55: 1219, 1975.PubMedCrossRefGoogle Scholar
  56. 56.
    Fam, W.M. and McGregor, M. Effect of coro nary vasodilator drugs on retrograde flow in areas of chronic myocardial ischemia. Circ. Res. 15: 355, 1964.PubMedGoogle Scholar
  57. 57.
    Macho, P. and Vatner, S.F. Effects of nitroglycerin and nitroprusside on large and small coronary vessels in conscious dogs. Circulation 64: 1101, 1981.PubMedCrossRefGoogle Scholar
  58. 58.
    Weintraub, W.S., Akizuki, S., Agarwal, J.B., Bodenheimer, M.M., Banka, V.S., and Helfant, R.H. Comparative effects of nitroglycerin and nifedipine on myocardial blood flow and contraction during flow-limiting coronary stenosis in the dog. Am. J. Cardiol. 50: 281, 1982.PubMedCrossRefGoogle Scholar
  59. 59.
    Cohen, M.V., Downey, J.M., Sonnenblick, E.H., and Kirk, E.S. The effects of nitroglycerin on coronary collaterals and myocardial contractility. J. Clin. Invest. 52: 2836, 1973.PubMedCrossRefGoogle Scholar
  60. 60.
    McGregor, M. The nitrates and myocardial ischemia. Circulation 66: 689, 1982.PubMedCrossRefGoogle Scholar
  61. 61.
    Cowan, C., Duran, P.V.M., Corsini, G., Goldschlager, N., and Bing, R.J. The effects of nitroglycerin on myocardial blood flow in man. Measured by coincidence counting and bolus injections of rubidium. Am. J. Cardiol. 24: 154, 1969.PubMedCrossRefGoogle Scholar
  62. 62.
    Knoebel, S.B., McHenry, P.L., Bonner, AJ., and Phillips, J.F. Myocardial blood flow in coronary artery disease. Effect of right artrial pacing and nitroglycerin. Circulation 47: 690, 1973.PubMedGoogle Scholar
  63. 63.
    Ganz, W. and Marcus, H.S. Failure of intracoronary nitroglycerin to alleviate pacing-induced angina. Circulation 46: 880, 1972.PubMedGoogle Scholar
  64. 64.
    Goldstein, R.E., Stinson, E.B., Schere, J.L., Seningen, R.P., Grehl, T.M., and Epstein, S.E. Intraoperative coronary collateral function in patients with coronary occlusive disease. Nitroglycerin responsiveness and angiographic correlations. Circulation 49: 298, 1974.PubMedGoogle Scholar
  65. 65.
    Horwitz, L.D., Gorlin, R., Taylor, W J., and Kemp, H.G. Effects of nitroglycerin on regional myocardial blood flow in coronary artery disease. J. Clin. Invest. 50: 1578, 1971.PubMedCrossRefGoogle Scholar
  66. 66.
    Maseri, A. Regional Myocardial Blood Flow in Man—Evaluation of Drugs. In Strauss, H.W., Pitt, B., and James, A.E. (eds.), Cardiovascular Nuclear Medicine. St. Louis: Mosby, 1974, p. 171.Google Scholar
  67. 67.
    Cohn, P.F., Maddox, D.E., Holman, B.L., Markis, J.E., Adams, D.F., and See, J.R. Effect of sublingually administered nitroglycerin on regional myocardial blood flow in patients with coronary artery disease. Am. J. Cardiol. 39: 672, 1977.PubMedCrossRefGoogle Scholar
  68. 68.
    Brown, B.G., Bolson, E., Petersen, R.B., Pierce, C.D., and Dodge, H.T. The mechanisms of nitroglycerin action: Stenosis vasodilatation as a major component of the drug response. Circulation 64: 1089, 1981.PubMedCrossRefGoogle Scholar
  69. 69.
    Berkenboom, G.M., Sobolski, J.C., and Degre, S.G. Oral sustained-release nitroglycerin in chronic stable angina: A multicenter, double-blind, randomized crossover trial. Am. J. Cardiol. 53: 15, 1984.PubMedCrossRefGoogle Scholar
  70. 70.
    Kaplan, K. Davison, R., Parker, M., Przybylek, J., Teagarden, J.R., and Lesch, M. Intravenous nitroglycerin for the treatment of angina at rest unresponsive to standard nitrate therapy. Am. J. Cardiol. 51: 694, 1983.PubMedCrossRefGoogle Scholar
  71. 71.
    Feldman, R.L., Marx, J.D., Pepine, CJ., and Conti, C.R. Analysis of coronary responses to various doses of intracoronary nitroglycerin. Circulation 66: 321, 1982.PubMedCrossRefGoogle Scholar
  72. 72.
    Reichek, N., Goldstein, R.E., Redwood, D.R., and Epstein, S.E. Sustained effects of nitroglycerin ointment in patients with angina pectoris. Circulation 50: 348, 1974.PubMedGoogle Scholar
  73. 73.
    Parker, J.O., Augustine, R J., Burton, J.R., West, R.O., and Armstrong, P.W. Effect of nitroglycerin in ointment on the clinical and hemodynamic response to exercise. Am. J. Cardiol. 38: 162, 1976.PubMedCrossRefGoogle Scholar
  74. 74.
    Parker, J.O. and Fung, H.-L. Transdermal nitroglycerin in angina pectoris. Am. J. Cardiol. 54: 471, 1984.PubMedCrossRefGoogle Scholar
  75. 75.
    Abrams, J. New nitrate delivery systems: Buccal nitroglycerin. Am. Heart J. 105: 848, 1983.PubMedCrossRefGoogle Scholar
  76. 76.
    Kimchi, A., Lee, G., Amsterdam, E., Fujii, K., Krieg, P., and Mason, D.T. Increased exercise tolerance after nitroglycerin oral spray: A new and effective therapeutic modality in angina pectoris. Circulation 67: 122, 1983.CrossRefGoogle Scholar
  77. 77.
    Udhoji, V.N. and Heng, M.K. Hemodynamic effects of high-dose sustained-action oral isosorbide dinitrate in stable angina. Am. J. Med. 76: 234, 1984.PubMedCrossRefGoogle Scholar
  78. 78.
    Markis, J.E., Gorlin, R., Mills, R.M., Williams, R.A., Schweitzer, P., and Ransil, B.J. Sustained effect of orally administered isosorbide dinitrate on exercise performance of patients with angina pectoris. Am. J. Cardiol. 43: 265, 1979.PubMedCrossRefGoogle Scholar
  79. 79.
    Lee, G., Mason, D.T., and DeMaria, A.N. Effects of long-term oral administration of isosorbide dinitrate on the antianginal response to nitroglycerin. Absence of nitrate cross-tolerance and self-tolerance shown by exercise testing. Am. J. Cardiol. 41: 82, 1978.PubMedCrossRefGoogle Scholar
  80. 80.
    Dalai, JJ., Yao, L., and Parker, J.O. Nitrate tolerance: Influence of isosorbide dinitrate on the hemodynamic and antianginal effects of nitroglycerin. J. Am. Coll. Cardiol. 2: 115, 1983.CrossRefGoogle Scholar
  81. 81.
    Warren, S.G., Bremer, D.L., and Orgain, E.S. Long-term propranolol therapy for angina pectoris. Am. J. Cardiol. 37: 420, 1976.PubMedCrossRefGoogle Scholar
  82. 82.
    Michaelson, S.P. and Wolfson, S. Role of propranolol in treatment of angina pectoris. Cardiovasc. Med. 3: 331, 1978.Google Scholar
  83. 83.
    Parker, J.O., West, R.O., and DiGiorgi, S. Hemodynamic effects of propranolol in coro-nary heart disease. Am. J. Cardiol. 21: 11, 1968.PubMedCrossRefGoogle Scholar
  84. 84.
    Friedman, M J., Temkin, L.P., Goldman, S., and Ovitt, T.W. Effects of propranolol on resting and postextrasystolic potentiated left ventricular function in patients with coronary artery disease. Am. Heart J. 105: 81, 1983.PubMedCrossRefGoogle Scholar
  85. 85.
    Marshall, R.C., Wisenberg, G., Schelbert, H.R., and Henze, E. Effect of oral propranolol on rest, exercise and postexercise left ventricular performance in normal subjects and patients with coronary artery disease. Circulation 63: 572, 1981.PubMedCrossRefGoogle Scholar
  86. 86.
    Rainwater, J., Steele, P., Kirch, D., LeFree, M., Jensen, D., and Vogel, R. Effect of propranolol on myocardial perfusion images and exercise ejection fraction in men with coronary artery disease. Circulation 65: 77, 1982.PubMedCrossRefGoogle Scholar
  87. 87.
    Hossack, R.F., Bruce, R.A., and Kusumi, F. Comprehensive analysis of exertional ECG changes before and after oral propranolol. Clin. Cardiol. 2: 270, 1979.CrossRefGoogle Scholar
  88. 88.
    Armstrong, P.W., Chiong, M.A., and Parker, J.O. Effects of propranolol on the hemodynamic coronary sinus blood flow and myocardial metabolic response to atrial pacing. Am. J. Cardiol. 40: 83, 1977.PubMedCrossRefGoogle Scholar
  89. 89.
    Mehta, J. and Mehta, P. Effects of propranolol therapy on platelet release and prostaglandin generation in patients with coronary heart disease. Circulation 6: 1294, 1982.CrossRefGoogle Scholar
  90. 90.
    Battock, DJ., Alvarez, H., and Chidsey, C.A. Effects of propranolol and isosorbide dinitrate on exercise performance and adrenergic activity in patients with angina pectoris. Circulation 39: 157, 1969.PubMedGoogle Scholar
  91. 91.
    Winniford, M.D., Huxley, R.L., and Hillis, L.D. Randomized, double-blind comparison of propranolol alone and a propranolol-verapamil combination in patients with severe angina of effort. J. Am. Coll. Cardiol. 1: 492, 1983.PubMedCrossRefGoogle Scholar
  92. 92.
    Shand, D.G. Propranolol. N. Engl.]. Med. 293: 280, 1975.CrossRefGoogle Scholar
  93. 93.
    Kern, M J., Ganz, P., Horowitz, J.D., Gaspar, J., Barry, W.H., Lorell, B.H., Grossman, W., and Mudge, G.H., Jr. Potentiation of coronary vasoconstriction by beta-adrenergic blockade in patients with coronary artery disease. Circulation 67: 1178, 1983.PubMedCrossRefGoogle Scholar
  94. 94.
    Miller, R.R., Olson, H.G., Amsterdam, E.A., and Mason, D.T. Propranolol withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy. N. Engl. J. Med. 293: 416, 1975.PubMedCrossRefGoogle Scholar
  95. 95.
    Goldstein, R.E., Corash, L.C., Tallman, J.F., Jr., Lake, C.R., Hyde, J., Smith, C.C., Capurro, N.L., and Anderson, J.C. Shortened platelet survival time and enhanced heart rate responses after abrupt withdrawal of propranolol from normal subjects. Am. J. Cardiol. 47: 115, 1981.Google Scholar
  96. 96.
    Shiroff, R.A., Mathis, J., Zelis, R., Schneck, D.W., Babb, J.D., Leaman, D.M., and Hayes, A.H., Jr. Propranolol rebound-a retrospective study. Am. J. Cardiol. 41: 778, 1978.PubMedCrossRefGoogle Scholar
  97. 97.
    Lindenfeld, J., Crawford, M.H., O’Rourke, R.A., Levine, S.P., Montiel, M.M., and Horwitz, L.D. Adrenergic responsiveness after abrupt propranolol withdrawal in normal subjects and in patients with angina pectoris. Circulation 62: 704, 1980.PubMedGoogle Scholar
  98. 98.
    Rangno, R.E., Nattel, S., and Lutterodt, A. Prevention of propranolol withdrawal mechanism by prolonged small dose propranolol schedule. Am. J. Cardiol. 49: 828, 1982.PubMedCrossRefGoogle Scholar
  99. 99.
    Pratt, C.M., Welton, D.E., Squires, W.G., Jr., Kirby, T.E., Hartung, G.H., and Miller, R.R. Demonstration of training effect during chronic ß-adrenergic blockade in patients with coronary artery disease. Circulation 64: 1125, 1981.PubMedCrossRefGoogle Scholar
  100. 100.
    Morris, K.G., Higginbotham, M.B., Coleman, R.E., Shand, D.G., and Cobb, F.R. Comparison of high-dose and medium-dose propranolol in the relief of exercise-induced myocardial ischemia. Am. J. Cardiol. 52: 7, 1983.PubMedCrossRefGoogle Scholar
  101. 101.
    Alderman, E.L., Davies, R.O., Crowley, J J., Lopes, M.G., Brooker, J.Z., Friedman, J.P., Graham, A.F., Matlof, H J., and Harrison, D.C. Dose response effectiveness of propranolol for the treatment of angina pectoris. Circulation 51: 964, 1975.PubMedGoogle Scholar
  102. 102.
    Thadani, U. and Parker, J.O. Propranolol in angina pectoris: Comparison of therapy given two and four times daily. Am. J. Cardiol. 46: 117, 1980.PubMedCrossRefGoogle Scholar
  103. 103.
    Parker, J.O., Porter, A., and Parker, J.D. Propranolol in angina pectoris: Comparison of long-acting and standard-formulation propranolol. Circulation 65: 1351, 1982.PubMedCrossRefGoogle Scholar
  104. 104.
    Frishman, W.H. Atenolol and timolol, two new systemic ß-adrenoceptor antagonists. N. Engl. J. Med. 36: 1456, 1982.Google Scholar
  105. 105.
    Brown, E J., Jr., Holman, B.L., Wynne, J., Swinford, R., and Cohn, P.F. Effect of timolol on exercise-induced reduction in regional ejection fraction in patients with coronary artery disease. Chest 84: 258, 1983.PubMedCrossRefGoogle Scholar
  106. 106.
    McLeod, A.A. and Shand, D.G. Atenolol: A long-acting beta-adrenoceptor antagonist. Ann. Intern. Med. 96: 244, 1982.PubMedGoogle Scholar
  107. 107.
    DiBianco, R., Singh, S.N., Shah, P.M., Newton, G.C., Miller, R.R., Nahormek, P., Costello, R.B., Laddu, A.R., Gottdiener, J.S., and Fletcher, R.D. Comparison of the antianginal efficacy of acebutolol and propranolol: A multicenter, randomized, double-blind placebo-controlled study. Circulation 65: 1119, 1982.PubMedCrossRefGoogle Scholar
  108. 108.
    Parker, J.O. Comparison of slow-release pindolol, standard pindolol, and propranolol in angina pectoris. Am. J. Cardiol. 51: 1062, 1983.PubMedCrossRefGoogle Scholar
  109. 109.
    Taylor, S.H., Silke, B., and Lee, P.S. Intravenous beta-blockade in coronary heart disease: Is cardioselectivity or intrinsic sympathomimetic activity hemodynamically useful? N. Engl. J. Med. 306: 631, 1982.PubMedCrossRefGoogle Scholar
  110. 110.
    Thadani, U., Davidson, C., Singleton, W., and Taylor, S.H. Comparison of five betaadrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in angina pectoris. Am. J. Med. 68: 243, 1980.PubMedCrossRefGoogle Scholar
  111. 111.
    Braunwald, E. Mechanism of action of calciumchannel-blocking agents. N. Engl. J. Med. 307: 1618, 1982.PubMedCrossRefGoogle Scholar
  112. 112.
    Maseri, A., Parodi, O., and Fox, K.M. Rational approach to the medical therapy of angina pectoris: The role of calcium antagonists. Prog. Cardiov. Dis. 25: 269, 1983.CrossRefGoogle Scholar
  113. 113.
    Weiner, D.A. and Klein, M.D. Verapamil therapy for stable exertional angina pectoris. Am. J. Cardiol. 50: 1153, 1982.PubMedCrossRefGoogle Scholar
  114. 114.
    Go, M., Jr. and Hollenberg, M. Improved efficacy of high-dose versus medium-and low-dose diltiazem therapy for chronic stable angina pectoris. Am. J. Cardiol. 53: 669, 1984.PubMedCrossRefGoogle Scholar
  115. 115.
    Sherman, L.G. and Liang, C.S. Nifedipine in chronic stable angina: A double-blind placebo-controlled crossover trial. Am. J. Cardiol. 51: 706, 1983.PubMedCrossRefGoogle Scholar
  116. 116.
    Bassan, M., Weiler-Ravell, D., and Shalev, O. The additive antianginal action of oral nifedipine in patients receiving propranolol. Circulation 66: 710, 1982.PubMedCrossRefGoogle Scholar
  117. 117.
    Amman, K. and Ryden, L. Comparison of metoprolol and verapamil in the treatment of angina pectoris. Am. J. Cardiol, 49: 821, 1982.CrossRefGoogle Scholar
  118. 118.
    DeMots, H., Rahimtoola, S.H., Kremkau, E.L., Bennett, W., and Mahler, D. Effects of ouabain on myocardial oxygen supply and demand in patients with chronic coronary artery disease. A hemodynamic, volumetric and metabolic study in patients without heart failure. J. Clin. Invest. 58: 312, 1976.PubMedCrossRefGoogle Scholar
  119. 119.
    Crawford, M.H., LeWinter, M., O’Rourke, R.A., Karliner, J.S., and Ross, J.E., Jr. Combined propranolol and digoxin therapy in angina pectoris. Ann. Intern. Med. 83: 449, 1975.PubMedGoogle Scholar
  120. 120.
    Aspirin Myocardial Infarction Study Research Group. A randomized, controlled trial of aspirin in persons recovered from myocardial infarction. JAMA 243: 661, 1980.CrossRefGoogle Scholar
  121. 121.
    Hood, W.B., Jr. More on sulfinpyrazone after myocardial infarction (editorial). N. Engl. J. Med. 306: 988, 1982.PubMedCrossRefGoogle Scholar
  122. 122.
    Frishman, W.H., Christodoulou, J., Webster, B., Smithen, C., Killip, T., and Scheidt, S. Aspirin therapy in angina pectoris: Effect on platelet aggregation exercise tolerance, and electrocar-diographic manifestations of ischemia. Am. Heart J. 92: 3, 1978.CrossRefGoogle Scholar
  123. 123.
    Orlando, J., Aronow, W.S., Cassidy, J., and Prakash, R. Effect of ethanol on angina pectoris. Ann. Intern. Med. 84: 652, 1976.PubMedGoogle Scholar
  124. 124.
    Solignac, A., Ferguson, R J., and Bourassa, M.G. External counterpulsation: Coronary hemodynamics and use in treatment of patients with stable angina pectoris. Cath. Cardiolvasc. Diag. 3: 37, 1977.CrossRefGoogle Scholar
  125. 125.
    Gruntzig, A. Transluminal dilatation of coronary artery stenoses. Lancet 1: 263, 1978.PubMedCrossRefGoogle Scholar
  126. 126.
    Dorros, G., Cowley, MJ., Simpson, J., Bentivoglio, L.G., Block, P.C., Bourassa, M., Detre, K., Gosselin, AJ., Gruntzig, A.R., Kelsey, S.F., Kent, K.M., Mock, M.B., Mullin, S.M., Myler, R.K., Passamani, E.R., Stertzer, S.H., and Williams, D.O. Percutaneous transluminal coronary angioplasty: Report of complications from the National Heart, Lung, and Blood Institute PTCA Registry. Circulation 67: 723, 1983.PubMedCrossRefGoogle Scholar
  127. 127.
    Kent, K.M., Bentivoglio, L.G., Block, P.C., Cowley, MJ., Dorros, G., Gosselin, AJ., Gruntzig, A., Myler, R.K., Simpson, J., Stertzer, S.H., Williams, D.O., Fisher, L., Gillespie, M J., Detre, K., Kelsey, S., Mullin, S.M., and Mock, M.B. Percutaneous transluminal coronary angioplasty: Report from the Registry of the National Heart, Lung, and Blood Institute. Am. J. Cardiol. 49: 2011, 1982.PubMedCrossRefGoogle Scholar
  128. 128.
    Kent, K.M., Bonow, R.O., Rosing, D.R., Ewels, CJ., Lipson, L.C., McIntosh, C.L., Bacharach, S., Green, M., and Epstein, S.E. Improved myocardial function during exercise after successful percutaneous transluminal coronary angioplasty. N. Engl. J. Med. 306: 441, 1982.PubMedCrossRefGoogle Scholar
  129. 129.
    Scholl, J.M., Chaitman, B.R., David, P.R., Duprias, G., Brevers, G., Val, P.G., Lesperance, J., and Bourassa, M.G. Exercise electrocardiography and myocardial scintigraphy in the serial evaluation of the results of percutaneous transluminal coronary angioplasty. Circulation 66: 380, 1982.PubMedCrossRefGoogle Scholar
  130. 130.
    Williams, D.O., Riley, R.S., Singh, A.K., and Most, A.S. Coronary circulatory dynamics before and after successful coronary angioplasty. J. Am. Coll. Cardiol. 1: 1268, 1983.PubMedCrossRefGoogle Scholar
  131. 131.
    Lee, G., Ikeda, R., Herman, I., Dwyer, R.M., Bass, M., Hussein, H., Kozina, J., and Mason, D.T. The qualitative effects of laser irradiation on human arteriosclerotic disease. Am. Heart J. 105: 885, 1983.PubMedCrossRefGoogle Scholar
  132. 132.
    Kannel, W.B. and Sorlie, P. Remission of clinical angina pectoris. The Framingham Study. Am. J. Cardiol. 42: 119, 1978.PubMedCrossRefGoogle Scholar
  133. 133.
    Kannel, W.B. and Feinleib, M. Natural history of angina pectoris in the Framingham Study: Progress and survival. Am. J. Cardiol. 29: 154, 1972.PubMedCrossRefGoogle Scholar
  134. 134.
    Frank, C.W., Weinblatt, E., and Shapiro, S. Angina pectoris in men: Prognostic significance or related medical factors. Circulation 47: 509, 1973.PubMedGoogle Scholar
  135. 135.
    White, P.D., Bland, E.F., and Miskall, E.W. Prognosis of angina pectoris: Long-term follow-up of 497 cases including note on 75 additional cases of angina pectoris decubitus. JAMA 123: 801, 1943.Google Scholar
  136. 136.
    Frank, C.W., Weinblatt, E., Shapiro, S., and Sager, R.V. Prognosis of men with coronary heart disease as related to blood pressure. Circulation 38: 432, 1968.PubMedGoogle Scholar
  137. 137.
    Heliovaara, M., Karvonen, MJ., Punsar, S., and Haapakoski, J. Importance of coronary risk factors in the presence or absence of myocardial ischemia. Am. J. Cardiol. 50: 1248, 1982.PubMedCrossRefGoogle Scholar
  138. 138.
    Blackburn, H. The prognostic importance of the electrocardiogram after myocardial infarction: Experience in the coronary drug project. Ann. Intern. Med. 77:677, 197 2.Google Scholar
  139. 139.
    Kotler, M.N., Tabatznik, B., Mower, M.M., and Tominaga, S. Prognostic significance of ventricular ectopic beats with respect to sudden death in the late postinfarction period. Circulation 47: 959, 1973.PubMedGoogle Scholar
  140. 140.
    Kannel, W.B., Boyle, J.T., McNamara, P., Quickenton, P., and Gordon, T. Precursors of sudden coronary death. Circulation 51: 606, 1975.PubMedGoogle Scholar
  141. 141.
    Lown, B. and Wolf, M. Approach to sudden death from coronary heart disease. Circulation 44: 130, 1971.PubMedGoogle Scholar
  142. 142.
    Robb, G.P. and Seltzer, F. Appraisal of the double two-step exercise test. A long-term follow-up study of 3325 men. JAMA 234: 727, 1975.CrossRefGoogle Scholar
  143. 143.
    Weiner, D.A., Ryan, TJ., McCabe, C.H., Chaitman, B.R., Sheffield, L.T., Ferguson, J.C., Fisher, L.D., and Tristani, F. Prognostic importance of a clinical profile and exercise test in medically treated patients with coronary artery disease. J. Am. Coll. Cardiol. 3: 772, 1984.PubMedCrossRefGoogle Scholar
  144. 144.
    Reeves, T J., Oberman, A., Jones, W.B., and Sheffield, L.T. Natural history of angina pectoris. Am. J. Cardiol. 33: 423, 1974.PubMedCrossRefGoogle Scholar
  145. 145.
    Bruschke, A.V., Proudfit, W.L., and Sones, F.M. Progress study of 490 consecutive nonsurgical cases of coronary diseases followed 5–9 years. I. Arteriographic correlations. Circulation 47: 1147, 1973.PubMedGoogle Scholar
  146. 146.
    Proudfit, W.L., Bruschke, A.V.G., and Sones, F.M., Jr. Natural history of obstructive coronary artery disease: Ten-year study of 601 nonsurgical cases. Prog. Cardiovasc. Dis. 22: 53, 1978.CrossRefGoogle Scholar
  147. 147.
    Proudfit, W J., Bruschke, A.V.G., MacMillan, J.P., Williams, G.W., and Sones, F.M., Jr. Fifteen year survival study of patients with obstruc-tive coronary artery disease. Circulation 68: 986, 1983.PubMedCrossRefGoogle Scholar
  148. 148.
    Murphy, M.L., Hultgren, N.H., Detre, K., Thomsen, J., and Takaro, T. Treatment of chronic stable angina. N. Engl. J. Med. 297: 621, 1977.PubMedCrossRefGoogle Scholar
  149. 149.
    Mock, M.B., Ringqvist, I., Fisher, L.D., Davis, K.B., Chaitman, B.R., Kouchoukos, N.T., Kaiser, G.C., Alderman, E., Ryan, TJ., Russell, R.O.,Jr., Mullin, S., Fray, D., Killip, T., III, and Participants in the Coronary Artery Surgery Study. Survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation 66: 562, 1982.PubMedCrossRefGoogle Scholar
  150. 150.
    Harris, P J., Lee, K.L., Harrell, F.E., Jr., Behar, V.S., and Rosati, R.A. Outcome in medically treated coronary artery disease: Ischemic events. Nonfatal infarction and death. Circulation 62: 718, 1980.PubMedGoogle Scholar
  151. 151.
    Califf, R.M., Tomabechi, Y., Lee, K.L., Phillips, H., Pryor, D.B., Harrell, F.E., Jr., Harris, PJ., Peter, R.H., Behar, V.S., Kong, Y., and Rosati, R.A. Outcome in one-vessel coronary artery disease. Circulation 67: 283, 1983.PubMedCrossRefGoogle Scholar
  152. 152.
    Lim, J.S., Proudfit, W.L., and Sones, F.M., Jr. Left main coronary arterial obstruction: Longterm follow-up of 141 nonsurgical cases. Am. J. Cardiol. 36: 131, 1975.PubMedCrossRefGoogle Scholar
  153. 153.
    Conley, MJ., Ely, R.L., Kisslo, J., Lee, K.L., McNeer, J.F., and Rosati, R.A. The prognostic spectrum of left main stenosis. Circulation 57: 947, 1978.PubMedGoogle Scholar
  154. 154.
    Takaro, T., Peduzzi, P., Detre, K.M., Hultgren, H.N., Murphy, M.L., van der Bel-Kahn, J., Thomsen, J., and Meadows, W.R. Survival in subgroups of patients with left main coronary artery disease: Veterans Administration Cooperative Study of Surgery for Coronary Arterial Occlusive Disease. Circulation 66: 14, 1982.PubMedCrossRefGoogle Scholar
  155. 155.
    Bruschke, A.V., Proudfit, E.L., and Sones, F.M. Progress study of 490 consecutive nonsurgical cases of coronary disease followed 5–9 tears. II. Ventriculographic and other correlations. Circulation 47: 1154, 1973.PubMedGoogle Scholar
  156. 156.
    Nelson, G.R., Cohn, P.F., and Gorlin, R. Prognosis in medically treated coronary artery disease. The value of the ejection fraction compared with other measurements. Circulation 52: 408, 1975.PubMedGoogle Scholar
  157. 157.
    Gross, H., Vaid, A.K., and Cohen, M.V. Prognosis in patients rejected for coronary revascularization surgery. Am. J. Med. 64: 9, 1978.PubMedCrossRefGoogle Scholar
  158. 158.
    Hammermesiter, K.E., DeRouen, T.A., and Dodge, H.T. Variables predictive of survival in patients with coronary disease: Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations. Circulation 59: 421, 1979.Google Scholar
  159. 159.
    Cohn, P.F., Harris, P., Barry, W.H., Rosati, R.A., Rosenbaum, P., and Waternaux, C. Prognostic importance of anginal symptoms in angiographically defined coronary artery disease. Am. J. Cardiol. 47: 233, 1981.PubMedCrossRefGoogle Scholar
  160. 160.
    Kent, K.M., Rosing, D.R., Ewels, CJ., Lipson, L., Bonow, R., and Epstein, S.E. Prognosis of asymptomatic or mildly symptomatic patients with coronary artery disease. Am. J. Cardiol. 49: 1823, 1982.PubMedCrossRefGoogle Scholar
  161. 161.
    Moise, Al., Theroux, P., Taeymans, Y., Waters, D.D., Lesperance, J., Fines, P., Descoings, B., and Robert, P. Clinical and angiographic factors associated with progression of coronary artery disease. J. Am. Coll. Cardiol. 3: 659, 1984.PubMedCrossRefGoogle Scholar
  162. 162.
    Marchandise, B., Bourassa, M.G., Chaitman, B.R., and Lesperance, J. Angiographic evaluation of the natural history of normal coronary arteries and mild coronary atherosclerosis. Am. J. Cardiol, 41: 216, 1978.PubMedCrossRefGoogle Scholar
  163. 163.
    ß-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA 247: 1707, 1982.CrossRefGoogle Scholar
  164. 164.
    The Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N. Engl. J. Med. 304: 801, 1981.CrossRefGoogle Scholar
  165. 165.
    Goldman, G.J. and Pichard, A.D. The natural history of coronary artery disease: Does medical therapy improve the prognosis? Prog. Cardiovasc, Dis. 25: 513, 1983.CrossRefGoogle Scholar
  166. 166.
    Victor, M.F., Likoff, MJ., Mintz, G.S., and Likoff, W. Unstable angina pectoris of new onset: A prospective clinical and arteriographic study of 75 patients. Am. J. Cardiol. 47: 228, 1981.PubMedCrossRefGoogle Scholar
  167. 167.
    Maseri, A. and Chierchia, S. Coronary artery spasm: Demonstration, definition, diagnosis, and consequences. Prog. Cardiovasc. Dis. 25: 169, 1982.PubMedCrossRefGoogle Scholar
  168. 168.
    Chierchia, S., Brunelli, C., Simonetii, I., Lazzari, M., and Maseri, A. Sequence of events in angina at rest: Primary reduction in coronary flow. Circulation 61: 759, 1980.PubMedGoogle Scholar
  169. 169.
    Oliva, P.B. Unstable rest angina with ST-segment depression: Pathophysiologic considerations and therapeutic implications. Ann. Int. Med. 100: 424, 1984.PubMedGoogle Scholar
  170. 170.
    Johnson, S.M., Mauritson, D.R., Winniford, M.D., Willerson, J.T., Firth, B.G., Cary, J.R., and Hillis, L.D. Continuous electrocardiographic monitoring in patients with unstable angina pectoris: Identification of high-risk subgroup with severe coronary disease, variant angina, and/or impaired early prognosis. Am. Heart J. 103: 4, 1982.PubMedCrossRefGoogle Scholar
  171. 171.
    Armstrong, P.W., Chiong, M.A., and Parker, J.O. The spectrum of unstable angina: Prognos-tic role of serum creatine kinase determination. Am. J. Cardiol. 49: 1849, 1982.PubMedCrossRefGoogle Scholar
  172. 172.
    Boden, W.E., Bough, E.W., Benham, I., and Shulman, R.S. Unstable angina with episodic ST segment elevation and minimal creatine kinase release culminating in extensive, recurrent infarction. J Am. Coll. Cardiol. 2: 11, 1983.PubMedCrossRefGoogle Scholar
  173. 173.
    Moses, J.W., Wertheimer, J.H., Bodenheimer, M.M., Banka, V.S., Feldman, M., and Helfant, R.H. Efficacy of nifedipine in rest angina refractory to propranolol and nitrates in patients with obstructive coronary artery disease. Ann. Intern. Med. 94: 425, 1981.PubMedGoogle Scholar
  174. 174.
    Gerstenblith, G., Ouyang, P., Achuff, S.C., Bulkley, B.H., Becker, L.C., Mellits, E.D., Baughman, K.L., Weiss, J.L., Flaherty, J.T., Kallman, C.H., Llewellyn, M., and Weisfeldt, M.L. Nifedipine in unstable angina: A double-blind, randomized trial. N. Engl. J. Med. 306: 885, 1982.PubMedCrossRefGoogle Scholar
  175. 175.
    Muller, J.E., Turi, Z.G., Pearle, D.L., Schneider, J.F., Serfas, D.H., Morrison, J., Stone, P.H., Rude, R.E., Rosner, B., Sobel, B.E., Tate, C., Scheiner, E., Robers, R., Hennekens, C.H., and Braunwald, E. Nifedipine and conventional therapy for unstable angina pectoris: A randomized, double-blind comparison. Circulation 69: 728, 1984.PubMedCrossRefGoogle Scholar
  176. 176.
    Sobel, M., Salzman, E.W., Davies, G.C., Han-din, R.I., Sweeney, J., Ploetz, J., and Kurland, G. Circulating platelet products in unstable angina pectoris. Circulation 63: 300, 1981.PubMedCrossRefGoogle Scholar
  177. 177.
    Folts, J.D., Gallagher, K., and Rowe, G.G. Blood flow reductions in stenosed canine coronary arteries: Vasospasm or platelet aggregation? Circulation 65: 248, 1982.PubMedCrossRefGoogle Scholar
  178. 178.
    Lewis, H.D., Davis, J.W., Archibald, D.G., Steinke, W.E., Smitherman, T.C., Doherty, J.E., III, Schnaper, H.W., LeWinter, M.M., Linares, E., Pouget, J.M., Sabharwal, S.C., Chesler, E., and DeMots, H. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina: Results of a Veterans Administration Cooperative Study. N. Engl. J. Med. 309: 396, 1983.PubMedCrossRefGoogle Scholar
  179. 179.
    Fuchs, R.M., Brin, K.P., Brinker, J.A., Guzman, P.A., Heuser, R.R., and Yin, F.C.P. Augmentation of regional coronary blood flow by intra-aortic balloon counterpulsation in patients with unstable angina. Circulation 68: 117, 1983.PubMedCrossRefGoogle Scholar
  180. 180.
    Williams, D.O., Riley, R.S., Singh, A.K., Gewirth, H., and Most, A.S. Evaluation of the role of coronary angioplasty in patients with unstable angina pectoris. Am. Heart J. 102: 1, 1981.PubMedCrossRefGoogle Scholar
  181. 181.
    Fulton, M., Lutz, W., Donald, K.W., Kirby, B J., Duncan, B., Morrison, S.L., Kerr, F., Julian, D.G., and Oliver, M.F. Natural history of unstable angina. Lancet 1: 860, 1972.PubMedCrossRefGoogle Scholar
  182. 182.
    Krauss, K.R., Hutter, A.M., and DeSanctis, R.W. Acute coronary insufficiency: Course and follow-up. Circulation 45 (Suppl. I): 66, 1972.Google Scholar
  183. 183.
    Gazes, P.C., Mobley, E.M., Jr., Faris, H.M., Jr., Duncan, R.C., and Humphries, G.B. Preinfarctional (stable) angina-a prospective study; Ten year follow-up. Prognostic significance of electrocardiographic changes. Circulation 48: 331, 1973.PubMedGoogle Scholar
  184. 184.
    Unstable Angina Pectoris: National Cooperative Study Group to Compare Medical and Surgical Therapy. I. Report of protocol and patient population. Am. J. Cardiol. 37: 896, 1976.CrossRefGoogle Scholar
  185. 185.
    Unstable Angina Pectoris: National Cooperative Study Group to Compare Surgical and Medical Therapy. II. In-hospital experience and initial follow-up results in patients with one, two and three vessel disease. Am. J. Cardiol. 42: 839, 1978.CrossRefGoogle Scholar
  186. 186.
    Unstable Angina Pectoris: National Cooperative Study Group to Compare Surgical and Medical Therapy. III. Results in patients with S-T segment elevation during pain. Am. J. Cardiol. 45: 819, 1980.CrossRefGoogle Scholar
  187. 187.
    Unstable Angina Pectoris: National Cooperative Study Group to Compare Medical and Surgical Therapy. IV. Results in patients with left anterior descending coronary artery disease. Am. J. Cardiol. 48: 517, 1981.CrossRefGoogle Scholar
  188. 188.
    Araki, H., Koiwaya, Y., Nakagaki, O., and Nakamura, M. Diurnal distribution of ST-segment elevation and related arrhythmias in patients with variant angina: A study by ambulatory ECG monitoring. Circulation 67: 995, 1983.PubMedCrossRefGoogle Scholar
  189. 189.
    Miller, D., Waters, D.D., Warnica, W., Szlachcic, J., Kreeft, J., and Theroux, P. Is variant angina the coronary manifestation of a generalized vasospastic disorder? N. Engl. J. Med. 304: 763, 1981.PubMedCrossRefGoogle Scholar
  190. 190.
    Pepine, CJ., Feldman, R.L., and Conti, C.R. Action of intracoronary nitroglycerin in refractory coronary artery spasm. Circulation 65: 411, 1982.PubMedCrossRefGoogle Scholar
  191. 191.
    Antman, E., Muller, J., Goldberg, S., MacAlpin, R., Rubenfire, M., Tabatznik, B., Liang, C.S., Heupler, F., Achuff, S., Reichek, N., Geltman, E., Kerin, N.Z., Neff, R.K., and Braunwald, E. Nifedipine therapy for coronary-artery spasm: Experience in 127 patients. N. Engl. J. Med. 302: 1269, 1980.PubMedCrossRefGoogle Scholar
  192. 192.
    Hill, J.A., Feldman, R.L., Conti, C.R., Hill, C.K., and Pepine, C.J. Long-term responses to nifedipine in patients with coronary spasm who have an initial favorable response. Am. J. Cardiol. 52: 24, 1983.CrossRefGoogle Scholar
  193. 193.
    Schroeder, J.S., Lamb, I.H., Bristow, M.R., Ginsburg, R., Hung, J., and McAuley, B. Pre-vention of cardiovascular events in variant angina by long-term diltiazem therapy. J. Am. Coll. Cardiol. 1: 1507, 1983.PubMedCrossRefGoogle Scholar
  194. 194.
    Freedman, S.B., Richmond, D.R., and Kelly, D.T. Long-term follow-up of verapamil and nitrate treatment for coronary artery spasm. Am. J. Cardiol. 50: 711, 1982.PubMedCrossRefGoogle Scholar
  195. 195.
    Winniford, M.D., Filipchuk, N., and Hillis, L.D. Alpha-adrenergic blockade for variant angina: A long-term, double-blind, randomized trial. Circulation 67: 1185, 1983.PubMedCrossRefGoogle Scholar
  196. 196.
    Waters, D.D., Szlachcic, J., Miller, D., and The-roux, P. Clinical characteristics of patients with variant angina complicated by myocardial infarction or death within 1 month. Am. J. Car-dial. 49: 658, 1982.CrossRefGoogle Scholar
  197. 197.
    Miller, D.D., Waters, D.D., Szlachcic, J., and Theroux, P. Clinical charcteristics associated with sudden death in patients with variant angina. Circulation 66: 588, 1982.PubMedCrossRefGoogle Scholar
  198. 198.
    Cohn, P.F. Prognosis and treatment of asymptomatic coronary artery disease. J. Am. Coll. Cardiol. 1: 959, 1983.PubMedCrossRefGoogle Scholar
  199. 199.
    McIntosh, H.D. and Garcia, J.A. The first decade of aortocoronary bypass grafting, 1967–1977. A review. Circulation 57: 405, 1978.PubMedGoogle Scholar
  200. 200.
    Vineberg, A. and Walker, J. The surgical treatment of coronary artery heart disease by internal mammary artery implantation: Report of 140 cases followed up to thirteen years. Dis. Chest 45: 190, 1964.PubMedCrossRefGoogle Scholar
  201. 201.
    Favaloro, R. Direct and indirect coronary surgery. Circulation 41: 1197, 1972.Google Scholar
  202. 202.
    Effler, D.B. Myocardial revascularization surgery since 1945. Its evolution and impact. J. Thorac. Cardiovasc. Surg. 72: 823, 1976.Google Scholar
  203. 203.
    Sawyer, P.N., Kaplitt, MJ., Sobel, S., and DiMaio, D. Application of gas endarterectomy to atherosclerotic peripheral vessels and coronary arteries. Clinical and experimental results. Circulation 36 (Suppl. I): 163, 1967.Google Scholar
  204. 204.
    Favaloro, R.G. Saphenous vein graft in the surgical treatment of coronary artery disease: Operative technique. J. Thorac. Cardiovasc. Surg. 58: 178, 1969.PubMedGoogle Scholar
  205. 205.
    Johnson, W.D., Flemma, RJ., Lepley, D., Jr., and Ellison, E.H. Extended treatment of severe coronary artery disease: A total surgical approach. Ann. Surg. 170: 460, 1969.PubMedCrossRefGoogle Scholar
  206. 206.
    Green, G.E. Internal mammary artery to coronary artery anastomosis: Three year experience with 165 patients. Ann. Thorac. Surg. 14: 260, 1972.PubMedCrossRefGoogle Scholar
  207. 207.
    Cohn, P.F. Clinical, angiographic and hemodynamic factors influencing selection of patients for coronary artery bypass surgery. Prog. Cardiovas. Dis. 18:223, 1975CrossRefGoogle Scholar
  208. 208.
    Report of Inter-Society Commission for Heart Disease Resources. Optimal resources for coronary artery surgery. Circulation 46: 325, 1972.Google Scholar
  209. 209.
    Alderman, E.L., Matlof, H J., Wexler, L., Shumway, N.E., and Harrison, D.C. Results of direct coronary artery surgery for the treatment of angina pectoris. N. Engl. J. Med. 388: 535, 1973.CrossRefGoogle Scholar
  210. 210.
    Morris, G.C., Jr., Reul, GJ., Howell, J.F., Crawford, E.S., Chapment, D.W., Beazley, H.L., Winters, W.L., Peterson, P.K., and Lewis, J.M. Follow-up results of distal coronary artery bypass for ischemic heart disease. Am. J. Car-dial. 29: 180, 1972.CrossRefGoogle Scholar
  211. 211.
    Lesperance, J., Bourassa, M.G., Biron, P., Campeau, L., and Saltiel, J. Aorta to coronary artery saphenous vein grafts. Preoperative angiographic criteria for successful surgery. Am. J. Cardiol. 30: 459, 1972.PubMedCrossRefGoogle Scholar
  212. 212.
    Grondin, C.M., Lapage, G., Castonguay, Y.R., Meere, C., and Grondin, P. Aortocoronary bypass graft. Initial blood flow through the graft, and early postoperative patency. Circulation 44: 815, 1971.PubMedGoogle Scholar
  213. 213.
    Spencer, F.C., Green, G.E., Tice, D.A., Wallsh, E., Mills, N.L., and Glassman, E. Coronary artery bypass grafts for congestive heart failure. A report of experiences with 40 patients. J. Thorac. Cardiovasc. Surg. 62: 529, 1971.PubMedGoogle Scholar
  214. 214.
    Oldham, H.N., Jr., Kong, Y., Bartel, A.G., Morris, JJ., Jr., Behar, V.S., Peter, R.H., Rosati, R.A., Young, W.G., Jr., and Sabiston, D.C., Jr. Risk factors in coronary artery bypass surgery. Arch. Surg. 105: 918, 1972.PubMedGoogle Scholar
  215. 215.
    Cohn, P.F., Gorlin, R., Herman, M.V., Sonnenblick, E.H., Horn, H.R., Cohn, L.H., and Collins, J.J., Jr. Relation between contractile reserve and prognosis in patients with coronary artery disease and a depressed ejection fraction. Circulation 51: 414, 1975.PubMedGoogle Scholar
  216. 216.
    Kennedy, J.W., Kaiser, G.C., Fisher, L.D., Fritz, J.K., Myers, W., Mudd, J.G., and Ryan, TJ. Clinical and angiographic predictors of operative mortality from the Collaborative Study in Coronary Artery Surgery (CASS). Circulation 63: 793, 1981.PubMedCrossRefGoogle Scholar
  217. 217.
    Helfant, R.H. Asynergy in coronary heart disease. Evolving clinical and pathophysiologic concepts. Ann. Intern. Med. 87: 475, 1977.PubMedGoogle Scholar
  218. 218.
    Cohn, L.H., Collins, J.J., Jr., and Cohn, P.F. Use of the augmented ejection fraction to select patients with severe left ventricular dysfunction for coronary revascularization. J. Thorac. Cardiovasc. Surg. 72: 835, 1976.PubMedGoogle Scholar
  219. 219.
    Nesto, R.W., Cohn, L.H., Collins, J.J., Jr., Wynne, J., Holman, L., and Cohn, P.F. Isotropic contractile reserve: A useful predictor of increased 5 year survival and improved postoperative left ventricular function in patients with coronary artery disease and reduced ejection fraction. Am. J. Cardiol. 50: 39, 1982.PubMedCrossRefGoogle Scholar
  220. 220.
    Kouchoukos, N.T., Oberman, A., Kirklin, J.W., Russeel, R.O., Jr., Karp, R.B., Pacifico, A.D., and Zorn, G.L. Coronary bypass surgery: Analysis of factors affecting hospital mortality. Circulation 62 (Suppl I): 84, 1980.Google Scholar
  221. 221.
    Chaitman, B.R., Alderman, E.L., Sheffield, L.T., Tong, T., Fisher, L., Mock, M.B., Weins, R.D., Kaiser, G.C., Roitman, D., Berger, R., Gersh, B., Schaff, H., Bourassa, M.G., Killip, T., and participating CASS medical centers. Use of survival analysis to determine the clinical significance of new Q waves after coronary bypass surgery. Circulation 67: 302, 1982.CrossRefGoogle Scholar
  222. 222.
    Raabe, D.S., Jr., Morise, A., Sbarbaro, J.A., and Gundel, W.D. Diagnostic criteria for acute myocardial infarction in patients undergoing coronary artery bypass surgery. Circulation 62: 869, 1980.PubMedGoogle Scholar
  223. 223.
    Aintablian, A., Hamby, R.I., Hoffman, I., Weisz, D., Voletti, C., and Wisoff, B.G. Significance of new Q waves after bypass grafting: Correlations between graft patency, ventriculogram, and surgical technique. Am. Heart J. 95: 429, 1978.PubMedCrossRefGoogle Scholar
  224. 224.
    Gray, R J., Matloff, J.M., Conklin, C.M., Ganz, W., Charuzi, Y., Wolfstein, R., and Swan, HJ.C. Perioperative myocardial infarction: Late clinical course after coronary artery bypass surgery. Circulation 66: 1185, 1982.PubMedCrossRefGoogle Scholar
  225. 225.
    Rahimtoola, S.H. Coronary bypass surgery for chronic angina-1981. A perspective. Circulation 65: 225, 1982.PubMedCrossRefGoogle Scholar
  226. 226.
    Campeau, L., Lespérance, J. and Bourassa, M.G. Natural history of saphenous vein aortocoronary bypass grafts. Mod. Concepts Cardiovasc. Dis. 53: 59, 1984.Google Scholar
  227. 227.
    Palac, R.T., Meadows, W.R., Hwang, M.H., Loeb, H.S., Pifarre, R., and Gunnar, R.M. Risk factors related to progressive narrowing in aortocoronary vein grafts studied 1 and 5 years after surgery. Circulation 66 (Suppl I): 40, 1982.Google Scholar
  228. 228.
    Chesebro,J.H., Fuster, V., Elveback, L.R., Clements, I.P., Smith, H.C., Homles, D.R., Jr., Bardsley, W.T., Pluth, J.R., Wallace, R.B., Puga, F J., Orszulak, T.A., Piehler, J.M., Danielson, G.K., Schaff, H.V., and Frye, R.L. Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations. N. Engl. J. Med. 310: 209, 1984.PubMedCrossRefGoogle Scholar
  229. 229.
    Levine, J.A., Bechtel, DJ., Gorlin, R., Cohn, P.F., Herman, M.V., Cohn, L.H., and Collins, JJ., Jr. Coronary artery anatomy before and after direct revascularization surgery: Clinical and cinearteriographic studies in 67 selected patients. Am. Heart J. 89: 561, 1975.PubMedCrossRefGoogle Scholar
  230. 230.
    Palac, R.T., Hwang, M.H., Meadows, W.R., Croke, R.P., Pifarre, R., Loeb, H.S., and Gun-nar, R.M. Progression of coronary artery disease in medically and surgically treated patients 5 years after randomization. Circulation 64 (Suppl II): 17, 1981.Google Scholar
  231. 231.
    Flaherty, J.T., Magee, P.A., Gardner, T.L., Potter, A., and MacAllister, N.P. Comparison of intravenous nitroglycerin and sodium nitroprusside for treatment of acute hypertension developing after coronary artery bypass surgery. Circulation 65: 1072, 1982.PubMedCrossRefGoogle Scholar
  232. 232.
    Ribeiro, P., Sapsford, R., Evans, T., Parcharidis, G., and Oakley, C. Constrictive pericarditis as a complication of coronary artery bypass surgery. Br. Heart J. 51: 205, 1984.PubMedCrossRefGoogle Scholar
  233. 233.
    Baddour, L.M. and Bisno, A.L. Recurrent cellulitis after saphenous venectomy for coronary bypass surgery. Ann. Intern. Med. 97: 493, 1982.PubMedGoogle Scholar
  234. 234.
    Miller, D.W., Jr. and Bruce, R.A. Physiologic improvement following coronary artery bypass surgery. Circulation 57: 831, 1978.PubMedGoogle Scholar
  235. 235.
    Weiner, D.A., McCabe, C.H., Roth, R.L., Cutler, S.S., Berger, R.L., and Ryan, TJ. Serial exercise testing after coronary artery bypass surgery. Am. Heart J. 101: 149, 1981.PubMedCrossRefGoogle Scholar
  236. 236.
    Sarma, R J. and Sanmarco, M.E. Reversal of exercise-induced hemodynamic and electrocardiographic abnormalities after coronary artery bypass surgery. Circulation 65: 684, 1982.PubMedCrossRefGoogle Scholar
  237. 237.
    Wainwright, R J., Brennand-Roper, D.A., Maisey, M.N., and Sowton, E. Exercise thallium-201 myocardial scintigraphy in the follow-up of aortocoronary bypass graft surgery. Br. Heart J. 43: 56, 1980.PubMedCrossRefGoogle Scholar
  238. 238.
    Block, T.A., Munag, J.A., and English, M.T. Improvement in exercise performance after unsuccessful myocardial revascularization. Am. J. Cardiol. 40: 673, 1977.PubMedCrossRefGoogle Scholar
  239. 239.
    Johnson, W.D., Kayser, K.L., Pedraza, P.M., and Shore, R.T. Employment patterns in males before and after myocardial revascularization surgery: A study of 2229 consecutive male patients followed for as long as 10 years. Circulation 65: 1086, 1982.PubMedCrossRefGoogle Scholar
  240. 240.
    Reduto, L.A., Lawrie, G.M., Reid, J.W., Whissenand, H.H., Noon, G.P., Kanon, D., DeBakey, M.E., and Miller, R.R. Sequential postoperative assessment of left ventricular performance with gated cardiac blood pool imaging following aortocoronary bypass surgery. Am. Heart J. 101: 59, 1981.PubMedCrossRefGoogle Scholar
  241. 241.
    Lim, Y.L., Kalif, V., Kelly, M J., Mason, P J., Currie, P J., Harper, R.W., Anderson, S.T., Federman, J., Sterling, G.R., and Pitt, A. Radionuclide angiographic assessment of global and segmental left ventricular function at rest and during exercise after coronary artery bypass graft surgery. Circulation 66: 972, 1982.PubMedCrossRefGoogle Scholar
  242. 242.
    Brundage, B.H., Massie, B.M., and Botvinick, E.H. Improved regional ventricular function after successful surgical revascularization. J. Am. Coll. Cardiol. 3: 902, 1984.PubMedCrossRefGoogle Scholar
  243. 243.
    Rubenson, D.S., Tucker, C.R., London, E., Miller, D.C., Stinson, E.B., and Popp, R.L. Two-dimensional echocardiographic analysis of segmental left ventricular wall motion before and after coronary artery bypass surgery. Circulation 66: 1025, 1982.PubMedCrossRefGoogle Scholar
  244. 244.
    Lawrie, G.M., Morris, G.C., Jr., Calhoon, J.H., Safi, H., Zamora, J.L., Beltengady, M., Baron, A., Silvers, A., and Chapman, D.W. Clinical results of coronary bypass in 500 patients at least 10 years after operation. Circulation 66 (Suppl I): 1, 1982.Google Scholar
  245. 245.
    Hammermeister, K.E. The effect of coronary bypass surgery on survival. Nog. Cardiovasc. Dis. 25: 297, 1983.CrossRefGoogle Scholar
  246. 246.
    Loop, F.D., Golding, L.R., Macmillan, J.P., Cosgrove, D.M., Lyte, B.W., and Sheldon, W.C. Coronary artery surgery in women compared with men: Analysis of risks and long-term results. J. Am. Coll. Cardiol. 1: 383, 1983.PubMedCrossRefGoogle Scholar
  247. 247.
    Oberman, A., Kouchoukos, N.T., Harrell, R.R., Holt, J.H., Jr., Russell, R.O., Jr., and Rackley, C.E. Surgical versus medical treatment in disease of the left main coronary artery. Lancet 2: 591, 1976.PubMedCrossRefGoogle Scholar
  248. 248.
    Chaitman, B.R., Fisher, L.D., Burassa, M.G., Davis, K., Rogers, W.J., Maynard, C., Tyras, D.H., Berger, R.L., Judkins, M.P., Ringqvist, I., Mock, M.B., and Killip, T., and participating CASS medical centers. Effect of coronary bypass surgery on survival patterns in subsets of patients with left main coronary artery disease. Report of the Collaborative Study in Coronary Artery Surgery (CASS). Am. J. Cardiol. 48: 765, 1981.PubMedCrossRefGoogle Scholar
  249. 249.
    Peduzzi, P. and Hultgren, H.N. Effect of medical vs. surgical treatment on symptoms in stable angina pectoris. The Veterans Administration Cooperative Study of Surgery for coronary arterial occlusive disease. Circulation 60: 888, 1979.PubMedGoogle Scholar
  250. 250.
    Aranow, W.S. and Stemmer, E.A. Two-year follow-up of angina pectoris: Medical or surgical therapy. Ann. Intern. Med. 82: 208, 1975.Google Scholar
  251. 251.
    Mathur, V.S. and Guinn, G.A. Prospective randomized study of coronary bypass surgery in stable angina. The first 100 patients. Circulation 52(Suppl. I ): 33, 1975.Google Scholar
  252. 252.
    Kloster, F., Kremkau, L., Rahimtoola, S., Rosch, J., Ritzman, L., and Kanarek, P.H. Prospective randomized study of coronary bypass surgery for chronic stable angina. N. Engl. J. Med. 300: 149, 1979.PubMedCrossRefGoogle Scholar
  253. 253.
    Fowles, R.E., Fitzgerald, J.W., Barry, W.H., and Hultgren, H.N. Long-term effects of coronary surgery versus medical therapy on exercise performance. Am. J. Cardiol. 41: 396, 1978.CrossRefGoogle Scholar
  254. 254.
    Pantely, G.A., Kloster, F.E., and Morris, C.D. Late exercise test results from a prospective randomized study of bypass surgery for stable angina. Circulation 68: 413, 1983.PubMedCrossRefGoogle Scholar
  255. 255.
    Takaro, T., Hultgren, H.N., Lipton, MJ., and Detre, K.M. The VA cooperative randomized study of surgery for coronary arterial occlusive disease. II. Subgroup with significant left main lesions. Circulation 54 (Suppl. 3): 116, 1976.Google Scholar
  256. 256.
    Detre, K., Peduzzi, P., Murphy, M., Hultgren, H., Thomsen, J., Oberman, A., Takaro, T., and the Veterans Administration Cooperative Study Group for Surgery for Coronary Arterial Occlusive Disease. Effect of bypass surgery on survival in patients in low-and high-risk subgroups delineated by the use of simple clinical variables. Circulation 63: 1329, 1981.PubMedCrossRefGoogle Scholar
  257. 257.
    The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. Eleven-year survival in the veterans administration randomized trial of coronary bypass surgery for stable angina. New Engl. J. Med. 311: 1333, 1984.CrossRefGoogle Scholar
  258. 258.
    European Coronary Surgery Study Group: Prospective randomized study of coronary artery bypass surgery in stable angina pectoris: A progress report on survival. Circulation 65 (Suppl. II): 67, 1982.Google Scholar
  259. 259.
    Whalen, R.E., Harrell, F.E., Jr., Lee, K.L., and Rosati, R.A. Survival of coronary artery disease patients with stable pain and normal left ventricular function treated medically or surgically at Duke University. Circulation 65 (Suppl. II): 49, 1982.PubMedCrossRefGoogle Scholar
  260. 260.
    CASS principal investigators and their associates. Myocardial infarction and mortality in the coronary artery surgery study (CASS) randomized trial. N. Engl. J. Med. 310: 750, 1984.CrossRefGoogle Scholar
  261. 261.
    Brown, C.A., Hutter, A.M., DeSanctis, R.W., Gold, H.K., Leinbach, R.C., Roberts-Niles, A., Austen, W.G., and Buckley, M.J. Prospective study of medical and urgent surgical therapy in randomizable patients with unstable angina pectoris: Results of in-hospital and chronic mortality and morbidity. Am. Heart J. 102: 959, 1981.PubMedCrossRefGoogle Scholar
  262. 262.
    Rahimtoola, S.H. Coronary bypass surgery for unstable angina. Circulation 69: 841, 1984.CrossRefGoogle Scholar
  263. 263.
    Hultgren, H.N., Shettigar, U.R., and Miller, D.C. Medical versus surgical treatment of unstable angina. Am. J Cardiol. 50: 663, 1982.PubMedCrossRefGoogle Scholar
  264. 264.
    Rahimtoola, S.H., Ninley, D., Grunkemeier, G., Tepley, J., Lambert, L., and Starr, A. Ten-year survival after coronary bypass surgery for unstable angina. N. Engl. J. Med. 308: 676, 1983.PubMedCrossRefGoogle Scholar
  265. 265.
    Sussman, E J., Goldberg, S., Poll, D.S., Macvaugh, H., III, Simson, M.B., Silber, S.A., and Kastor, J.A. Surgical therapy of variant angina associated with nonobstructive coronary disease. Ann. Intern. Med. 94: 771, 1981.PubMedGoogle Scholar
  266. 266.
    Betriu, A., Pomar, J.L., Bourassa, M.G., and Grondin, C.M. Influence of partial sympathetic denervation on the results of myocardial revascularization in variant angina. Am. J. Cardiol. 51: 661, 1983.PubMedCrossRefGoogle Scholar
  267. 267.
    Waters, D.D., Bouchard, A., and Theroux, P. Spontaneous remission is a frequent outcome of variant angina. J. Am. Coll. Cardiol. 9: 195, 1983.CrossRefGoogle Scholar
  268. 268.
    Bott-Silverman, C. and Heupler, F.A., Jr. Natural history of pure coronary artery spasm in patients treated medically. J Am. Coll. Cardiol. 2: 200, 1983.PubMedCrossRefGoogle Scholar
  269. 269.
    Levine, S.A. and Kauvar, A J. Association of angina pectoris or coronary thrombosis with mitral stenosis. J. Mt. Sinai Hosp. 8: 754, 1942.Google Scholar
  270. 270.
    Befeler, B., Kamen, A.R., and MacLeod, M.B. Coronary artery disease and left ventricular function in mitral stenosis. Chest 57: 435, 1970.PubMedCrossRefGoogle Scholar
  271. 271.
    Tadavarthy, S.M., Vlodaver, Z., and Edwards, J.E. Coronary atherosclerosis in subjects with mitral stenosis. Circulation 54: 519, 1976.PubMedGoogle Scholar
  272. 272.
    Basta, L.L., Raines, D., Najjar, S., and Kioschos, J.M. Clinical hemodynamic and coronary angiographic correlates of angina pectoris in patients with severe aortic valve disease. Br. Heart J. 37: 150, 1975.PubMedCrossRefGoogle Scholar
  273. 273.
    Moraski, R.E., Russell, R.O., Jr., Mantle, J.A., and Rackley, C.E. Aortic stenosis, angina pectoris, coronary artery disease. Cath. Cardiovasc. Dis. 2: 157, 1976.CrossRefGoogle Scholar
  274. 274.
    Graboys, T.B. and Cohn, P.F. The prevalence of angina pectoris and abnormal coronary arteriograms in severe aortic valcular disease. Am. Heart J. 93: 683, 1977.PubMedCrossRefGoogle Scholar
  275. 275.
    Hakki, A.H., Kimbiris, D., Iskandrian, A.S., Segal, B.L., Mintz, G.S., and Bemis, C.E. Angina pectoris and coronary artery disease in patients with severe aortic valvular disease. Am. Heart J. 100: 441, 1980.PubMedCrossRefGoogle Scholar
  276. 276.
    Bonchek, L.I., Anderson, R.P., and Rosch, J. Should coronary arteriography be performed routinely before valve replacement. Am. J. Cardiol. 31: 462, 1973.PubMedCrossRefGoogle Scholar
  277. 277.
    Exadactylos, N., Sugrue, D.D., and Oakley, C.M. Prevalence of coronary artery disease in patients with isolated aortic valve stenosis. Br. Heart J 51: 121, 1984.PubMedCrossRefGoogle Scholar
  278. 278.
    Lardani, H., Serrano, J.A., and Villamil, R J. Hemodynamics and coronary angiography in idiopathic hypertrophic subaortic stenosis. Am. J. Cardiol. 41: 476, 1978.PubMedCrossRefGoogle Scholar
  279. 279.
    Scharf, S., Wexler, J., Longnecker, R.E., and Blaufox, M.D. Cardiovascular disease in patients on chronic hemodialytic therapy. Prog. Cardiovasc. Dis. 25: 343, 1980.CrossRefGoogle Scholar
  280. 280.
    Weinrauch, L.A., D’Elia, J.A., Healy, R.W., Gleason, R.E., Takacs, F J., Libertino, J.A., and Leland, O.S. Asymptomatic coronary artery disease: Angiography in diabetic patients before renal transplantation. Relation of findings to postoperative survival. Ann. Intern. Med. 296: 1436, 1977.Google Scholar
  281. 281.
    Hillis, L.D. and Cohn, P.F. Noncardiac surgery in patients with coronary artery disease: Risks, precautions, and perioperative management. Arch. Intern. Med. 138: 972, 1978.PubMedCrossRefGoogle Scholar
  282. 282.
    Wells, P.H. and Kaplan, J.A. Optimal management of patients with ischemic heart disease for noncardiac surgery by complementary anesthesiologist and cardiologist interaction. Am. Heart J. 102: 1029, 1981.PubMedCrossRefGoogle Scholar
  283. 283.
    McCollum, C.H., Garcia-Rinaldi, R., Graham, J.M., and DeBakey, M.E. Myocardial revascularization prior to subsequent major surgery in patients with coronary artery disease. Surgery 81: 302, 1977.PubMedGoogle Scholar
  284. 284.
    Edwards, W.H., Mulherin, J.L., and Walker, W.E. Vascular reconstructive surgery following myocardial revascularization. Ann. Surg. 187: 653, 1978.PubMedCrossRefGoogle Scholar
  285. 285.
    Barnes, R.W., Liebman, P.R., Marszalek, P.B., Kirk, C.L., and Goldman, M.H. The natural history of asymptomatic carotid disease in patients under going cardiovascular surgery. Surgery 90: 1075, 1981.PubMedGoogle Scholar
  286. 286.
    Chee, T.P., Prakash, N.S., Desser, K.B., and Benchimol, A. Postoperative supraventricular arrhythmias and the role of prophylactic digoxin in cardiac surgery. Am, Heart J. 104: 974, 1982.CrossRefGoogle Scholar
  287. 287.
    Oka, Y., Frishman, W., Becker, R.M., Kadish, A., Strom, J., Matsumoto, M., Orkin, L., and Frater, R. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 10. Betaadrenoceptor blockade and coronary artery surgery. Am. Heart J. 99: 255, 1980.PubMedCrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1985

Authors and Affiliations

  • Peter F. Cohn

There are no affiliations available

Personalised recommendations